← Retour au Screener

Sector: Santé
Open in Terminal → CMPSLive chart · Key metrics · News · Smart money

COMPASS Pathways

CMPS Small Cap

Healthcare · Medical Care Facilities

Mis à jour: Jun 18, 2026, 22:21 UTC

10,93 €
+4.94% aujourd'hui
52W: 1,96 € – 12,88 €
52W Low: 1,96 € Position: 82.2% 52W High: 12,88 €

Price Chart

Indicateurs clés

P/E Ratio
Cours/Bénéfice
Forward P/E
P/E prévisionnel
P/S Ratio
Cours/Ventes
EV/EBITDA
Valeur d'entreprise/EBITDA
Rend. dividende
Rendement annuel du dividende
Cap. boursière
1,5 Md €
Capitalisation boursière
Croissance du CA
Croissance du CA sur un an
Marge bénéficiaire
Marge nette
ROE
-68.48%
Rentabilité des capitaux propres
Beta
2.51
Sensibilité au marché
Positions vendeuses
5.5%
% du flottant vendu à découvert
Volume moyen
4,099,515
Volume quotidien moyen

Valuation Analysis

Signal
N/A
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
Achat Fort
15 analysts
Avg. Price Target
19,37 €
+77.17% upside
Target Range
6,98 € – 61,09 €

About the Company

Sector: Healthcare Industry: Medical Care Facilities Country: United Kingdom Employees: 156 Exchange: NMS

COMPASS Pathways en bref

COMPASS Pathways (CMPS) is currently trading at 10,93 € with a market capitalization of 1,5 Md €. The 52-week range spans from 1,96 € to 12,88 €; the current price is 15.1% below the yearly high.

💰 Dividende

COMPASS Pathways currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

15 analystes évaluent COMPASS Pathways (CMPS) au consensus : Achat Fort. L'objectif de cours moyen est de 19,37 €, soit un potentiel de +77.17% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 6,98 € à 61,09 €.

COMPASS Pathways : la thèse d'investissement en détail

COMPASS Pathways (CMPS) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United Kingdom. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Wall Street consensus sits at Strong Buy with an average price target implying roughly 77.17% upside from current levels — analyst sentiment is firmly constructive.

Le scénario baissier

With a beta near 2.51, the share price moves sharply more than the broader market — drawdowns in market corrections can be unusually severe and require strong nerves.

À surveiller

  • The analyst consensus price target implies 77.17% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Points forts
  • Consensus des analystes : Strong Buy
  • Bilan solide avec faible endettement (D/E 16.32)
  • Free cash flow positif
Points faibles
  • Forte volatilité (Bêta 2.51)

Aperçu technique

MM 50 jours
8,70 €
+25.68% vs. cours
MM 200 jours
6,24 €
+75.24% vs. cours
Sous le plus haut 52s
−15.1%
12,88 €
Au-dessus du plus bas 52s
+456.9%
1,96 €

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

Risque de marché (Bêta)
2.51 · Élevé
Évolue plus que le marché global
Positions vendeuses
5.5% · Élevé
% du flottant vendu à découvert
Dette/Capitaux propres
16.32 · Faible
Dette totale / capitaux propres

The data points to above-average price swings, elevated short interest (5.5%).

Trading Data

50-Day MA: 8,70 €
200-Day MA: 6,24 €
Volume: 3,536,431
Avg. Volume: 4,099,515
Short Ratio: 1.88
P/B Ratio: 5.18x
Debt/Equity: 16.32x
Free Cash Flow: 29 M €

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy COMPASS Pathways?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut